← Back to Methodology
RQS Scoring Log

Turkesterone

Peptide-Adjacent· Animal / In Vitro· Scored May 2026· View compound profile →
37 /100
Weak Evidence
7 dimensions · 100 points total · Methodology by PeptideClear
Dimension Breakdown
DimensionScoring NotesScore
Study Design
Primarily rodent and insect studies for anabolic/ergogenic effects. One small Russian human study (often cited) has significant methodological limitations. Animal/in vitro.
2 / 25
Sample Size
No validated human efficacy RCTs. The cited human study is uncontrolled.
0 / 20
Replication
Animal findings partially replicated but inconsistently. In vitro protein synthesis findings exist but cell culture doesn't translate reliably to human ergogenic effect.
10 / 20
Journal Impact Factor
Published in low-tier journals and some Russian phytochemistry publications. No high-impact journal primary data.
8 / 15
Funding Independence
Academic and Russian institute funded. Independent from supplement industry for original research (though supplement industry now heavily markets based on this research).
7 / 10
Population Diversity
Animal/in vitro. Not applicable.
5 / 5
Researcher h-Index
V.N. Syrov (Uzbekistan Institute of Plant Chemistry) — the original ecdysterone researcher has a profile in Eastern European phytochemistry literature, but Western database h-Index is difficult to confirm.
5 / 5
Animal Only Note
This score reflects evidence in humans. Animal and in vitro evidence may be substantially stronger than the score suggests — this compound has not yet been studied in human trials.